Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Anti-obesity Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Anti-obesity Drugs Market, by Mechanism of action,2018-2027 (USD Billion)
1.2.3. Anti-obesity Drugs Market, by Drug type,2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Anti-obesity Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Anti-obesity Drugs Market Dynamics
3.1. Anti-obesity Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Anti-obesity Drugs MarketIndustry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Anti-obesity Drugs Market, by Mechanism of action
5.1. Market Snapshot
5.2. Global Anti-obesity Drugs Market by Mechanism of action, Performance - Potential Analysis
5.3. Global Anti-obesity Drugs Market Estimates & Forecasts by Mechanism of action2017-2027 (USD Billion)
5.4. Anti-obesity Drugs Market, Sub Segment Analysis
5.4.1. Peripherally Acting Drugs
5.4.2. Centrally Acting Drugs
Chapter 6. Global Anti-obesity Drugs Market, by Drug type
6.1. Market Snapshot
6.2. Global Anti-obesity Drugs Market by Drug type, Performance - Potential Analysis
6.3. Global Anti-obesity Drugs Market Estimates & Forecasts by Drug type2017-2027 (USD Billion)
6.4. Anti-obesity Drugs Market, Sub Segment Analysis
6.4.1. Prescription Drugs
6.4.2. OTC Drugs
Chapter 7. Global Anti-obesity Drugs Market, Regional Analysis
7.1. Anti-obesity Drugs Market, Regional Market Snapshot
7.2. North America Anti-obesity Drugs Market
7.2.1. U.S.Anti-obesity Drugs Market
7.2.1.1. Mechanism of actionbreakdown estimates & forecasts, 2017-2027
7.2.1.2. Drug typebreakdown estimates & forecasts, 2017-2027
7.2.2. CanadaAnti-obesity Drugs Market
7.3. Europe Anti-obesity Drugs Market Snapshot
7.3.1. U.K. Anti-obesity Drugs Market
7.3.2. Germany Anti-obesity Drugs Market
7.3.3. France Anti-obesity Drugs Market
7.3.4. Spain Anti-obesity Drugs Market
7.3.5. Italy Anti-obesity Drugs Market
7.3.6. Rest of EuropeAnti-obesity Drugs Market
7.4. Asia-PacificAnti-obesity Drugs Market Snapshot
7.4.1. China Anti-obesity Drugs Market
7.4.2. India Anti-obesity Drugs Market
7.4.3. JapanAnti-obesity Drugs Market
7.4.4. Australia Anti-obesity Drugs Market
7.4.5. South Korea Anti-obesity Drugs Market
7.4.6. Rest of Asia PacificAnti-obesity Drugs Market
7.5. Latin America Anti-obesity Drugs Market Snapshot
7.5.1. Brazil Anti-obesity Drugs Market
7.5.2. Mexico Anti-obesity Drugs Market
7.6. Rest of The World Anti-obesity Drugs Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Boehringer Ingelheim GmbH

8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Arena Pharmaceuticals Inc.
8.2.3. Takeda Pharmaceuticals Company Limited
8.2.4. Zydus Cadila
8.2.5. Rhythm Pharmaceuticals
8.2.6. Merck & Co. Inc.
8.2.7. Eisai Co. Ltd.
8.2.8. Novo Nordisk A/S
8.2.9. Orexigen Therapeutics Inc.
8.2.10. GlaxoSmithKline PLC
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption